Mitchell Sinkler & Starr’s Bristol-Myers Squibb BMY Stock Holding History

Mitchell Sinkler & Starr’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$341K	Sell	5,917 -53	-0.9%	-$3.04K	0.14%	127
2026 Q1	$362K	Sell	5,970 -1,160	-16%	-$67.6K	0.17%	113
2025 Q4	$385K	Sell	7,130 -1,140	-14%	-$54.8K	0.17%	111
2025 Q3	$373K	Sell	8,270 -25	-0.3%	-$1.17K	0.17%	113
2025 Q2	$384K	Sell	8,295 -485	-6%	-$23.8K	0.18%	108
2025 Q1	$535K	Sell	8,780 -110	-1%	-$6.41K	0.15%	100
2024 Q4	$503K	Sell	8,890 -600	-6%	-$33.5K	0.13%	102
2024 Q3	$491K	Buy	9,490 +485	+5%	+$22.8K	0.12%	107
2024 Q2	$382K	Sell	9,005 -8,560	-49%	-$383K	0.1%	113
2024 Q1	$953K	Sell	17,565 -9,577	-35%	-$488K	0.24%	78
2023 Q4	$1.39M	Buy	27,142 +12,137	+81%	+$637K	0.25%	77
2023 Q3	$871K	Buy	15,005 +2,230	+17%	+$137K	0.27%	60
2023 Q2	$817K	Hold	12,775	–	–	0.23%	78
2023 Q1	$885K	Sell	12,775 -7,295	-36%	-$515K	0.26%	73
2022 Q4	$1.44M	Buy	20,070 +9,360	+87%	+$706K	0.46%	48
2022 Q3	$761K	Buy	10,710 +1,360	+15%	+$98.7K	0.3%	64
2022 Q2	$720K	Sell	9,350 -260	-3%	-$19.8K	0.26%	63
2022 Q1	$702K	Sell	9,610 -175	-2%	-$11.8K	0.22%	74
2021 Q4	$610K	Hold	9,785	–	–	0.18%	80
2021 Q3	$579K	Sell	9,785 -300	-3%	-$19.8K	0.52%	60
2021 Q2	$674K	Buy	10,085 +50	+0.5%	+$3.26K	0.61%	56
2021 Q1	$634K	Sell	10,035 -500	-5%	-$31.1K	0.61%	56
2020 Q4	$653K	Sell	10,535 -500	-5%	-$30.7K	0.62%	56
2020 Q3	$665K	Hold	11,035	–	–	0.68%	50
2020 Q2	$649K	Hold	11,035	–	–	0.74%	45
2020 Q1	$615K	Hold	11,035	–	–	0.8%	44
2019 Q4	$708K	Hold	11,035	–	–	0.75%	46
2019 Q3	$560K	Buy	11,035 +3,450	+45%	+$162K	0.72%	51
2019 Q2	$344K	Sell	7,585 -965	-11%	-$44.9K	0.39%	74
2019 Q1	$408K	Sell	8,550 -2,000	-19%	-$99.6K	0.47%	69
2018 Q4	$548K	Hold	10,550	–	–	0.68%	52
2018 Q3	$655K	Sell	10,550 -1,000	-9%	-$59.3K	0.69%	51
2018 Q2	$639K	Sell	11,550 -4,350	-27%	-$235K	0.7%	55
2018 Q1	$1.01M	Sell	15,900 -175	-1%	-$11.3K	1.15%	33
2017 Q4	$985K	Hold	16,075	–	–	1.46%	26
2017 Q3	$1.02M	Hold	16,075	–	–	1.61%	25
2017 Q2	$896K	Hold	16,075	–	–	1.47%	27
2017 Q1	$874K	Sell	16,075 -6,005	-27%	-$329K	1.42%	32
2016 Q4	$1.29M	Sell	22,080 -1,617	-7%	-$88.4K	1.81%	20
2016 Q3	$1.28M	Sell	23,697 -325	-1%	-$20.9K	2%	20
2016 Q2	$1.77M	Hold	24,022	–	–	2.41%	10
2016 Q1	$1.53M	Sell	24,022 -300	-1%	-$18.9K	2.12%	12
2015 Q4	$1.67M	Sell	24,322 -5,600	-19%	-$370K	2.28%	12
2015 Q3	$1.77M	Buy	29,922 +100	+0.3%	+$6.34K	2.28%	10
2015 Q2	$1.98M	Buy	29,822 +352	+1%	+$23.2K	2.34%	11
2015 Q1	$1.9M	Sell	29,470 -15	-0.1%	-$939	2.14%	12
2014 Q4	$1.74M	Hold	29,485	–	–	1.95%	22
2014 Q3	$1.51M	Sell	29,485 -1,700	-5%	-$84.9K	1.69%	23
2014 Q2	$1.51M	Sell	31,185 -900	-3%	-$44.4K	1.63%	23
2014 Q1	$1.67M	Sell	32,085 -515	-2%	-$27.4K	1.87%	19
2013 Q4	$1.73M	Sell	32,600 -1,000	-3%	-$50.9K	1.95%	16
2013 Q3	$1.55M	Sell	33,600 -51,495	-61%	-$2.26M	1.78%	22
2013 Q2	$3.8M	Buy	+85,095	New	+$3.69M	0.83%	35

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mitchell Sinkler & Starr's BMY Position: Q2 2026 in Review

Mitchell Sinkler & Starr reduced its Bristol-Myers Squibb (BMY) stake by 0.89% in Q2 2026, selling an estimated $3.04K and leaving 5,917 shares worth $341K. The position accounts for 0.14% of the portfolio, ranked #127.

Mitchell Sinkler & Starr first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.8M in Q2 2013. 781 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Mitchell Sinkler & Starr held 5,917 shares of Bristol-Myers Squibb worth $341K as of Q2 2026.
Mitchell Sinkler & Starr sold 53 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.04K.
Bristol-Myers Squibb made up 0.14% of Mitchell Sinkler & Starr's portfolio in Q2 2026, its #127 holding.
Mitchell Sinkler & Starr first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
Mitchell Sinkler & Starr's Bristol-Myers Squibb position peaked at $3.8M in Q2 2013.
781 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Mitchell Sinkler & Starr's 13F filing for Q2 2026, filed 21 Jul 2026.